公开(公告)号：US20220071959A1

公开(公告)日：2022-03-10

申请号：US17528510

申请日：2021-11-17

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Xingfeng BAO ,  Diana ALBU ,  Mary WOODALL-JAPPE

IPC: A61K31/415 ,  A61K31/7068 ,  C07K16/28 ,  A61K39/00

Abstract: The present invention provides methods and compositions for treating cancer by administering an EP4 antagonist in combination with radiation therapy, antibody therapy and/or anti-metabolite chemotherapy.

公开(公告)号：US20170182003A1

公开(公告)日：2017-06-29

申请号：US15312980

申请日：2015-05-21

Applicant: EISAI R&D MANAGEMENT CO., LTD.

Inventor： Xingfeng BAO ,  Diana ALBU ,  Mary WOODALL-JAPPE

IPC: A61K31/415 ,  A61K39/00 ,  A61K31/7068

CPC classification number: A61K31/415 ,  A61K31/7068 ,  A61K39/00 ,  A61K2039/505 ,  A61K2300/00 ,  C07K16/2818 ,  C07K16/2827

Abstract: The present invention provides methods and compositions for treating cancer by administering an EP4 antagonist in combination with radiation therapy, antibody therapy and/or anti-metabolite chemotherapy.